Alcohol Use and Antiobesity Medication Treatment.
作者信息
Miller-Matero Lisa R, Yeh Hsueh-Han, Ma Lisiyu, Jones Rebecca A, Nadolsky Spencer, Medcalf Adam, Foster Gary D, Cardel Michelle I
机构信息
Center for Health Policy & Health Services Research, Henry Ford Health, Detroit, Michigan.
Behavioral Health Services, Henry Ford Health, Detroit, Michigan.
出版信息
JAMA Netw Open. 2024 Nov 4;7(11):e2447644. doi: 10.1001/jamanetworkopen.2024.47644.
Abstract
摘要
相似文献
1
Alcohol Use and Antiobesity Medication Treatment.酒精使用与抗肥胖药物治疗
JAMA Netw Open. 2024 Nov 4;7(11):e2447644. doi: 10.1001/jamanetworkopen.2024.47644.
2
Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement.抗肥胖药物治疗后的术后体重减轻及关节置换后的翻修风险
JAMA Netw Open. 2025 Feb 3;8(2):e2461200. doi: 10.1001/jamanetworkopen.2024.61200.
3
Prevalence of Antiobesity Treatment and Weight-Inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes in the United States.美国2型糖尿病患者中抗肥胖治疗和致体重增加的降糖药物的流行情况。
Clin Ther. 2022 Mar;44(3):e35-e44. doi: 10.1016/j.clinthera.2022.01.003. Epub 2022 Jan 30.
4
National trends in antiobesity medication use.抗肥胖药物使用的全国趋势。
Arch Intern Med. 2003 May 12;163(9):1046-50. doi: 10.1001/archinte.163.9.1046.
5
Long-Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change.在一家虚拟体重管理诊所中，同时开具多种药物并结合行为改变的长期体重减轻结果。
Obes Sci Pract. 2025 Jan 8;11(1):e70036. doi: 10.1002/osp4.70036. eCollection 2025 Feb.
6
Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016.肥胖治疗：2011 至 2016 年美国基于诊间的就诊中药物治疗肥胖趋势。
Mayo Clin Proc. 2021 Dec;96(12):2991-3000. doi: 10.1016/j.mayocp.2021.07.021. Epub 2021 Oct 30.
7
Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States.美国开始使用抗肥胖药物患者的处方趋势和临床特征。
Diabetes Obes Metab. 2021 Jul;23(7):1542-1551. doi: 10.1111/dom.14367. Epub 2021 Mar 25.
8
Application of the nonlinear Blinder-Oaxaca decomposition to study racial/ethnic disparities in antiobesity medication use in the United States.应用非线性布伦纳-奥克萨卡分解法研究美国抗肥胖药物使用中的种族/民族差异。
Res Social Adm Pharm. 2013 Jan-Feb;9(1):13-26. doi: 10.1016/j.sapharm.2012.02.006. Epub 2012 May 2.
9
Cardiovascular co-medication among users of antiobesity drugs: a population-based study.抗肥胖药物使用者的心血管联合用药：一项基于人群的研究。
Pharm World Sci. 2010 Dec;32(6):752-8. doi: 10.1007/s11096-010-9432-7. Epub 2010 Aug 29.
10
Extracts of Moringa oleifera leaves from different cultivation regions show both antioxidant and antiobesity activities.来自不同种植区域的辣木叶提取物具有抗氧化和抗肥胖活性。
J Food Biochem. 2020 Jul;44(7):e13282. doi: 10.1111/jfbc.13282. Epub 2020 May 20.
引用本文的文献
1
Impact of weight loss and lifestyle modifications on liver fibrosis in MASLD and MetALD: A cohort study.体重减轻和生活方式改变对代谢相关脂肪性肝病（MASLD）和代谢相关脂肪性肝炎（MetALD）肝纤维化的影响：一项队列研究。
Biomed Rep. 2025 Jul 25;23(4):158. doi: 10.3892/br.2025.2036. eCollection 2025 Oct.
Zotero 插件